Reuters reveals Tens of millions of J&J COVID-19 shots sit at Baltimore factory


Reuters broke the news that an estimated 30 million to 50 million doses of Johnson & Johnson’s COVID-19 vaccine made earlier this year sit idle in Emergent BioSolutions Inc’s plant in Baltimore, awaiting a green light from U.S. regulators to ship. A source said Emergent is waiting for the U.S. Food and Drug Administration to approve release of those doses. Emergent shares opened nearly 1% higher following the Reuters report.

Article Tags

Topics of Interest: Health

Type: Reuters Best

Sectors: Business & Finance

Regions: North America

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *